MedPath logo

HERBESSER R100 CAPSULES 100 mg

Prescription Only
Drug type: Therapeutic
ATC code: C08DB01
Dosage form: CAPSULE
Route of administration: ORAL
Active ingredient: DILTIAZEM HCl; DILTIAZEM HCL

INDICATIONS

  • Essential hypertension (mild to moderate)
  • Angina pectoris, variant angina pectoris

CONTRAINDICATIONS (HERBESSER R is contraindicated in the following patients.)

  1. Patients with severe congestive heart cardiac failure [Symptoms of cardiac failure may be aggravated].
  2. Patients with second or third degree atrioventricular block or sick sinus syndrome (persistent sinus bradycardia) (less than 50 beats/ minute), sinus arrest, sinoatrial block, etc.) [Depression of cardiac stimulation and cardiac conduction may occur excessively].
  3. Patients with a history of hypersensitivity to any of the ingredients of this product.
  4. Pregnant women or women who may possibly be pregnant [See “Use during pregnancy, Delivery or lactation” section – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information].
  5. Patients receiving ivabradine hydrochloride. [See “Drug Interactions” section – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information.]

DOSAGE AND ADMINISTRATION

  • Essential hypertension (mild to moderate)

    Usually, for adults, I00 mg to 200 mg of diltiazem hydrochloride is orally administered once daily. The dosage may be adjusted according to the patient’s age and symptoms.

  • Angina pectoris, variant angina pectoris

    Usually, for adults, 100 mg of Diltiazem hydrochloride is orally administered once daily. If the effect is insufficient, the dosage may be increased to 200 mg once daily.

Registrant
MITSUBISHI TANABE PHARMA SINGAPORE PTE. LTD.
Approval Date
1998-09-29
Approval Number
SIN10062P
Manufacturer
PT Mitsubishi Tanabe Pharma Indonesia Mitsubishi Tanabe Pharma Factory Ltd.
Licence Holder
MITSUBISHI TANABE PHARMA SINGAPORE PTE. LTD.